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Summary 
Lymphocyte trafficking is an essential process in immune and inflammatory functions which 
can be thought to contain at least two main components: adhesion and migration. Whereas 
adhesion molecules such as the sdectins are known to mediate the homing of leukocytes from 
the blood to the endothelium, the chemoattractant substances responsible for the migration of 
specific subsets of lymphocytes to sites of infection or inflammation are largely unknown. Here 
we show that two molecules in the chemokine (for chemoattractant cytokine) superfamily, human 
macrophage inflammatory protein lc~ (MIP-la) and MIP-lfl, do not share identical attractant 
activities for lymphocyte subpopulations. When analyzed in vitro in microchemotaxis experiments, 
HuMIP-1B tends to attract CD4 + T lymphocytes, with some preference for T cells of the naive 
(CD45RA) phenotype. HuMIP-lot, when tested in parallel with HuMIP-lfl, is a more potent 
lymphocyte chemoattractant with a broader range of concentration-dependent chemoattractant 
specificities. HuMIP-lo~ at a concentration of 100 pg/ml attracts B ceUs and cytotoxic T cells, 
whereas at higher concentrations (10 ng/ml), the migration of these cells appears diminished, 
and the migration of CD4 + T  cells is enhanced. Thus, in this assay system,  HuMIP-lc~ and 
-18 have differential attractant activities for subsets of immune effector cells, with HuMIP-la 
having greater effects than HuMIP-I~,  particularly on B cells. 
T 
he  chemokines  are  a  superfamily of  small  proteins 
(8,000-14,000  Mr) secreted primarily by leukocytes and 
related by a conserved four-cysteine motif (1, 2). These pro- 
teins have been imphcated in a wide range of acute and chronic 
inflammatory processes, as well as other immunoregulatory 
functions. The superfamily's two branches are classified as 
the C-X-C and the C-C groups, as defined by the spacing 
of the first two cysteines in the conserved motif. Early charac- 
terizations of the two branches of the chemokine superfamily 
showed that, generally, C-X-C chemokines, such as the neu- 
trophil attractant  and activating factors  (IL-8),  melanoma 
growth-stimulatory activity (MGSA/gro),  neutrophil-acti- 
rating peptide 2 (NAP-2), and a neutrophil-activating pro- 
tein  derived  from  epithelial  cells  (ENA-78),  are  potent 
chemoattractants and activators of neutrophils but not mono- 
cytes (3-6),  whereas the C-C chemokines, including such 
molecules as human monocyte  chemotactic protein I (MCP-1) 
RANTES, and the macrophage inflammatory proteins la 
and 18 (HuMIP-lc~ and -1~ proteins exhibit chemoattrac- 
rant potential for monocytes, but not neutrophils (7-9). C-C 
chemokines also have effects on other blood leukocytes. MCP-1 
and RANTES are potent direct mediators of the rdease of 
histamine by human basophils (10-12), whereas RANTES, 
and to a lesser extent HuMIP-lcr  are chemoattractants and 
activators of eosinophils (13, 14). The regulatory signals im- 
paired by C-C chemokines can also be negative. MIP-la has 
been reported to be a unique and specific inhibitor of the 
proliferation of hematopoietic stem cells (15). 
A poorly understood area of lymphocyte biology is the 
specific targeting of lymphocyte effector cell subpopulations 
during an immune challenge or inflammatory response. We 
have shown that the C-C chemokine RANTES is a selective 
chemoattractant for T lymphocytes of the memory pheno- 
type in vitro (9),  and IL-8 has been reported to attract T 
cells in vitro and in vivo (16). A recent report has implicated 
human MIP-1/5 in the induction of the adhesive properties 
of T  lymphocytes, and found this molecule to be localized 
to lymph node endothelium (17). In addition, we have dis- 
cussed the possible roles of the MIP-1 proteins in differential 
attraction of lymphocytes (1), and their roles in a three-step 
model of leukocyte adhesion has been postulated (18). A 
detailed  analysis of their chemoattractant properties, how- 
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chemoattractant potentials of the two closely related human 
chemokines HuMIP-loe and -13 for human lymphocytes, as 
determined using purified recombinant proteins in an in vitro 
microchemotaxis system. 
Materials and Methods 
Preparation  of  Recombinant  Chemokines.  A cDNA for HuMIP-1B 
was isolated by screening a human cultured T cell cDNA library 
with an oligonucleotide of 50 residues corresponding to the first 
50 coding sequence nucleotides of the hI-I400 molecule (19). For 
HuMIP-lc~, a cDNA was isolated using PCR, employing an an- 
tisense primer made against nucleotides 283 to 236 in the pub- 
lished LD78 sequence (20) and was used in the reverse transcrip- 
tion of 7.5 mg of total RNA from an antigen-induced cultured 
functional T cell line. The sense  primer was made to match nucleo- 
tides  -19 to 3 in the LD78 sequence and used in concert with 
the antisense primer in a PCR of the cDNA. Mammalian expres- 
sion system-derived material was used for preliminary determina- 
tions of HuMIP-lc~ and -1/~ attractant potentials. In these experi- 
ments, the cDNA inserts were subdoned into the pILK5  expression 
vector, transfected into the human embryonic kidney cell line 293, 
and transiently expressed as described  for RANTES (9). Confirma- 
tion and quantitation of the chemoattractant activities  was obtained 
using purified recombinant I-IuMIP-la and -1B chemokines.  These 
were produced in Escherichia  coli by linking cDNAs encoding the 
mature, secreted  forms of the molecules (devoid  of the mammalian 
signal sequence) to the bacterial STII promoter in an expression 
plasmid. 
HuMIP-lc~ was purified from E. coli fermentation medium after 
first removing the cells by low-speed centrifugation. The pH of 
the supematant was then adjusted to ,,o3 with phosphoric acid and 
the resulting precipitate was removed  by a second low-speed spin. 
After readjustment to pH 5, the HuMIP-lc~ contained in the clear 
supernatant was captured on a bare silica  column and eluted with 
an ethanolAodium chloride buffer at the same pH. The silica  Pool 
was diafihered into a dilute Tris-hydroxy  amino methane buffer at 
neutral pH and loaded  onto a DEAE-Sepharose  column, from which 
HuMIP-lc~ was eluted with a step up in ionic strength. The product 
was further purified  by C4 reversed-phase  HPLC using a linear gra- 
dient of acetonitrile. Solvent was removed by capture and elution 
from DEAE-Sepharose as described  above, and the purified product 
was formulated for administration by diafiltration into an isotonic 
citrate/sodium  chloride  buffer. HuMIP-lo~  purified  using this proce- 
dure contained <1 EU/mg as determined in the limulus amoebo- 
cyte lysate test. HuMIP-IB was purified from recombinant E. coli 
by dispersing cell paste in phosphate buffer at neutral pH, followed 
by homogenization at ,'~20,000 psi. The homogenate was adjusted 
to pH 3 and centrifuged briefly to pellet cell debris. The superna- 
tant was decanted and adjusted to pH 6 with sodium hydroxide, 
initiating the precipitation of HuMIP-1/~. After centrifugation, the 
supernatant was discarded and the pellet dissolved with ",~1 M 
NaC1/20 mM acetic acid, pH 3. This solution was then applied 
to a column of phenyl Toyopearl equilibrated in the same buffer. 
After analysis by reversed-phase HPI.C, selected fractions of the 
column flow-through were pooled and diafiltered across a 5-kD 
cellulose membrane versus 20 mM acetic acid, pH '~3.2. Purity 
as  judged by HPLC was >99%. Pyrogen was not detectable  in LAL 
assay at a sensitivity limit of 5 EU/mg. 
Lymphocyte  Migration Assays.  Lymphocyte  migration in response 
to either HuMIP-lc~ and -1B conditioned media or purified recom- 
binant chemokines was assessed. Leukocytes  isolated from whole 
blood were depleted  of  monocytes  by a two-step adherence  to plastic, 
resulting in a cell distribution (as evaluated  by immunocytochem- 
ical detection) routinely <1% monocytes (9, 21). Test substances 
and controls are tested in the same assay, each in duplicate wells 
of the microchemotaxis chamber. After incubation for I h, fixing, 
and staining as described (9, 21), lymphocyte migration is evalu- 
ated using either an image analyzer, or by counting the cells by 
eye. In the first instance, a migration index (MI) is calculated as 
the area of  lower surface of filter occupied  by cells after stimulation 
with chemoattractant divided by the area of falter occupied by un- 
stimulated, randomly migrating cells (9, 21). In the second, the 
MI is the actual number of cells migrating in response to the test 
substance divided by the number  of cells that have randomly 
migrated in the control chambers. 
Immunohistochemical Phenotyping of Responding Lymphocytes. 
Migrating lymphocytes were phenotyped immunocytochemically 
using a panel of mAbs and APAAP staining as described (9, 21). 
The mAb used were: T4, TS, Pan T, Pan B, and CD45RO/UCHL-1 
(Dako, High Wycombe,  UK); and CD45RA antibody Coulter (Hi- 
aleah, FL). The distribution of control populations of identically 
prepared monocyte-depleted  PBL in the experiments  using the same 
antibodies was 21  _+ 6% B cells and 77 _+  17% T cells of which 
49  +  8% were CD4 cells, 26  +  6% were CD8, 43  _+ 6% were 
CD45RO,  and 52  _+  4% were CD45KA.  22  _+  3% cells were 
HLA-DR  ~  . 
Results and Discussion 
Initial experiments were done with recombinant HuMIP-lcr 
and -13 proteins obtained from a mammalian expression system 
as described for RANTES (9). Though the mature secreted 
forms of HuMIP-lot and -1/$ are nearly 70%  identical in 
predicted sequence,  they display biochemically distinct be- 
haviors,  possibly due to glycosylation differences (1). After 
transfection of the human embryonic kidney cell line 293 with 
either HuMIP-lo~ or -1/$ cDNA expression constructs, pro- 
teins of ",~8,000 and 12,000 daltons, respectively, are released 
into the cell culture medium (1). We initially tested the ability 
of such 293 cell supematants containing recombinant HuMIP- 
lc~ and -13 to attract lymphocytes isolated from peripheral 
blood using a microchemotaxis assay system (9, 21). In n  = 
6  initial  experiments,  conditioned media  from  293  cells 
producing recombinant HuMIP-lot and -1/$ both contained 
a potent lymphocyte attracting activity (>~ the positive con- 
trol, 5% zymosan-activated plasma, at optimal dilution of 
chemokine-containing cell  culture supernatants),  whereas 
media from control transL*cted cells had no effect (1, and data 
not shown). 
To confirm that these effects were due solely to the pres- 
ence of the recombinant chemokines, we next obtained purified 
recombinant HuMIP-lot and -13 using a bacterial expres- 
sion system. The cumulative results of four experiments, each 
determination performed in duplicate using the purified recom- 
binant chemokines, are shown in Fig. 1. In these experiments, 
HuMIP-lot and -13 were tested in parallel in the same assay, 
in order to make direct comparisons of their activities pos- 
sible,  and a MI was determined by directly counting the 
number of responding cells. Both HuMIP-lol and HuMIP- 
1/$ show potent chemoattractant activity over a wide con- 
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representing the MI at each concentration of chemokine. How- 
ever, interesting differences in the patterns of response to the 
two chemokines can be noted. The curve for HuMIP-1B (e, 
Fig.  1)  shows  a  maximal  MI  of ,,o2.7  at  100  pg/ml  of 
chemokine, with the curve decreasing uniformly at either 
higher or lower concentration of the chemokine. Such bell- 
shaped profiles are typical of in vitro chemotaxis assays. In 
the case of HuMIP-lcx, however, the pattern is different ([], 
Fig. 1). Not only is HuMIP-lot more potent than HuMIP- 
1/~, with a maximal MI of ,v4.2 at 100 pg/ml, but the MI 
curve is consistently biphasic, with a second distinct peak 
at a concentration of 10 ng/ml (MI "~3.7) of the chemokine. 
In all cases, the control buffer tested in parallel showed no 
chemoattractant activity (A,  Fig.  1). 
Immunohistochemical phenotyping of the migrating lym- 
phocytes revealed differences in the attractant properties of 
these two related cytokines. Initially the assays were run at 
the concentration of chemokine that produced the highest 
MI (100 pg/ml for each chemokine), and phenotyping per- 
formed on the migrating cells using a panel of primary mAbs 
that recognize B cells, MHC class II surface antigens, all T 
cells,  or  the  T  cell  subset-specific markers  CD4,  CD8, 
CD45RO,  or CD45RA  (9, 21).  CD45RA  and CD45RO 
define two different isoforms of the leukocyte common an- 
tigen CD45. These isoforms have been thought of as markers 
that may differentiate naive from memory T cells (22, 23). 
Upon  stimulation of virgin or naive CD45RA  T  cells,  a 
differentiation event occurs that  results in the loss  of the 
CD45RA  isoform and the concomitant expression of the 
CD45ILO isoform. It is within the CD45RO population of 
cells that T  cell memory is thought to reside (24-28). 
There is a marked migration of T but not B cells, in re- 
sponse to 100 pg/ml of HuMIP-lfl (Fig.  2). Further, there 
is no significant migration of CD8 + cells  to HuMIP-1/~. 
Migration  is  largely preferential to  cells  that  are CD4 +. 
HuMIP-1/~ also shows a modest, but statistically significant 
tendency to  attract  T  cells  of the CD45RA + phenotype 
(Fig. 2). This can be contrasted with what has been seen with 
RANTES,  which  causes  the  preferential  migration  of 
CD45RO + T cells while not affecting the CD4 +/CD45RA + 
cells (9).  Lastly,  the distribution of responding phenotypes 
is similar at other concentrations of the recombinant HuMIP- 
18 chemokine (data not shown). 
Since  maximal  lymphocyte attraction  to  recombinant 
HuMIP-lc~ was biphasic, lymphocytes responding to each 
of these concentrations (100  pg/ml  and  10  ng/ml)  were 
separately phenotyped and distinct differences in concentration- 
specific attractive activities were noted. First, it was observed 
that HuMIP-la was a more potent T lymphocyte attractant 
than HuMIP-1/~. At 100 pg/ml, HuMIP-la attracted 345 
_  47 T  lymphocytes (Fig.  3) as compared with 227  _  12 
for HuMIP-IB  (Fig.  2). Second, whereas neither HuMIP- 
1/3, in these experiments, nor RANTES, in previous experi- 
ments (9 and Schall, T., and K. Bacon, unpublished data), 
had any attractant effects on B cells or CD8 + cells in the 
assay, HuMIP-lc= at 100 pg/ml is a potent attractant of both 
of these lymphocyte populations, in addition to CD4 + cells 
(Fig. 3). At this concentration, the MI for B cells in response 
to HuMIP-lot was ,u8.3 (125  +_  17 vs. 15  +  10). In addi- 
tion, nearly three and a half times the CD8 + T  cells (175 
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Figure  1.  PBL migration in response  to purified recombinant HuMIP-tcx 
and -1/3 chemokines. Concentration-response curves for lymphocyte migra- 
tion to HuMIP-13 (@) and HuMIP-lo~ ([]) or control (formulation buffer 
diluted identically into cell culture medium) (A). Points represent the migra- 
tion index (MI) which is defined as the number of cells counted on the 
lower surface of the filter after incubation with the chemokines in the 
mierochemotaxis chamber divided by the number of cells that have migrated 
to the lower surface of the filters in control wells of the chamber. (Dotted 
line) MI value for randomly migrating cells. Results are expressed as mean 
migration  indices with error bars representing SEM for n = 4 experiments. 
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Figure 2.  Immunophenotyping of cells responding to  HuMIP-1B. 
Phenotype of lymphocytes migrating in response to 100 pg/ml concentra- 
tion of purified recombinant HuMIP-1/3 (solid bars) or identically diluted 
formulation buffer in cell culture media (control,  hatched bars) as deter- 
mined by immunocytochemical  analysis. PBL assayed as in Fig.  1 were 
phenotyped using primary antibodies recognizing B cells, MHC class II 
surface antigens, all T cells, or the T cell subset-specific markers CD4, 
CD8, CD45RO, or CD45RA. Histograms represent mean + SEM number 
of positively staining  cells which have migrated to the undersurface of the 
filters as counted per five high power fields (,  =  4 experiments). 
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Figure 3.  Phenotype of lymphocytes  migrating in response  to 100 pg/ml 
of purified recombinant HuMIP-lo~. Immunohistochemical analysis  oflym- 
phocytes responding at 100 pg/ml of HuMIP-lo~ showing migration of 
B cells and CD8 + T cells. The assay was scored as described in Fig. 2. 
+  17 vs. 47  +  4) responded to 100 pg/ml of HuMIP-lc~. 
There was no significant difference in the number of CD45RA 
vs. CD45RO cells responding to HuMIP-la. At higher rel- 
ative concentrations (10 ng/ml) of HuMIP-lc~, there was a- 
reduction of the migration of B cells and CD8 + T cells (Fig. 
4).  Whereas the response of these cells is abrogated, there 
is a substantial  increase in the numbers of CD4 + T cells that 
migrate (266  +  32 at 10 ng/ml, Fig. 4, vs. 140  _+ 34 at 100 
pg/ml,  Fig.  3).  Again  the  proportion  of CD45RA  and 
CD45RO positive cells was not significantly different. Thus, 
a 100-fold increase in the concentration of HuMIP-lot results 
in a difference in its chemoattractant potential where the re- 
sponse of B cells and cytotoxic T  cells is reduced and that 
of Th cells enhanced. 
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Figure  4.  Phenotype of lymphocytes migrating in response to higher 
concentrations of recombinant HuMIP-lo~. The response of lymphocytes 
at 10 ng/ml of HuMIP-la showing abrogation  of B cell and cytotoxic 
T  cell migration, and enhancement  of CD4 + T  cell migration. 
The data in this study show differences in the lymphocyte 
chemoattractant potentials for the closely related cytokines 
HuMIP-loc and -13.  Whereas HuMIP-1/3 tends to attract 
CD4 + T lymphocytes, HuMIP-lot appears to be a more po- 
tent chemoattractant with a broader specificity, attracting B 
cells and cytotoxic T ceils as well as CD4 + T cells. HuMIP-lcx 
does not appear to distinguish between lymphocytes of the 
memory and naive phenotypes, and differentiates between 
the types of cell attracted in a concentration-dependent fashion. 
The specific attractant activities of the HuMIP- 1 proteins also 
differ from what we have shown for RANTES, which causes 
the selective migration of monocytes and T lymphocytes of 
the memory phenotype, while not affecting T cells of other 
phenotypes (9). Thus, this one small family of cytokines dis- 
plays attractant effects on most subpopulations of lympho- 
cyte effector cells. A recent report by Tanaka et al. (17) sug- 
gests that MIP-lfl specifically enhances the adhesive properties 
of T lymphocytes. Although the cells acted upon in that study 
appear to be primarily CD8 + T  cells,  the report provides 
no evidence that MIP-lfl acts exclusively on these cells. In 
fact, since RANTES did not enhance adhesion in that re- 
port, but dearly is chemoattractant for T  cells (9, 29), the 
Tanaka et al. report may suggest that chemokines differen- 
tially induce adhesion and migration in lymphocyte subpopu- 
lations.  Moreover, the possibility cannot be excluded that the 
lymphocyte purification and separation methods used in the 
adhesion study may have predisposed the cells to activation 
along an adhesion pathway in response to the chemokine. 
The finding that HuMIPI-fl is localized on LN endothelium 
is compelling, but further experimentation is required to de- 
termine if this form of the chemokine is acting in inflamma- 
tory processes at all, and whether these processes are primarily 
adhesion, or migration, or some combination of both. 
The mechanisms by which the chemokines attract different 
subpopulations of lymphocytes is not dear. The ability of 
HuMIP-lot to attract distinct cell types in a concentration- 
specific fashion has some precedent in the chemokine super- 
family. The related RANTES cytokine attracts monocytes 
in vitro at "ol00-fold higher relative concentration than that 
optimal for memory Th cell attraction (9),  and neither cell 
population responds at the optimal concentration for the other. 
Similarly, IL-8 attracts neutrophils at concentrations 10-100- 
fold higher than those optimal for T cells (16). We have re- 
cently cloned a receptor that binds all of the C-C chemokines 
with varying affinities, but appears to bind and signal in re- 
sponse to HuMIP-lcx most strongly (30).  Experiments are 
currently underway to  determine the distribution  of this 
receptor among lymphocyte subpopulations,  and to ascer- 
tain if it participates in the attractant specificities  observed 
in these experiments. 
The recruitment of lymphocytes to areas of injury or in- 
fection is a hallmark of host defense. In addition, immune- 
mediated inflammatory disorders such as rheumatoid arthritis 
and asthma, among others, are characterized by the migra- 
tion and persistence of specific subpopulations of lympho- 
cyte effector cells. The data presented here, and those in a 
previous report (9), show that a small group of related cyto- 
kines can affect the migration of many of the major subsets 
1824  HuMIP-lo~ and -lfl Chemokines  Are Lymphocyte Chemoattractants of lymphocyte effector cells. Moreover, their differential at- 
tractant effects on distinct populations of lymphocytes may 
be dependent on not only differences in structure and bio- 
chemistry but also on differences in the relative concentra- 
tion of a single cytokine. Understanding these effects may 
provide clues as to the workings of lymphocyte traf~cking 
in vivo, and may allow for therapeutic intervention in inflam- 
matory and autoimmune disorders. 
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